SERNOVA Forum: Community User: COLOGNE79

Du solltest Sernova doch langsam kennen 😉

Abbsie, dein Ernst 😅

Letzte Chance für günstig?🤔

Da kriegt gleich richtig Lust nachzulegen!

Danke für die News Ellen und Entreri!!! Top!!!!

November 30, 2020 - 9:00 a.m. EST LONDON, ONTARIO – November 30, 2020 – Sernova Corp. (TSX-V:SVA)(OTCQB:SEOVF)(FSE:PSH), a leading clinical-stage regenerative medicine therapeutics company, is pleased to announce that Dr. Piotr Witkowski, principal investigator in Sernova's ongoing Phase I/II clinical trial, A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation will present data and observations from the trial in an oral presentation delivered at the American Society of Transplant Surgeons 21st Annual State of the Art Winter Symposium. Dr. Witkowski, Director, Pancreatic and Islet Transplant Program at the University of Chicago, is scheduled to deliver his presentation, Islet Allotransplantation Into Pre-Vascularized Sernova Cell Pouch™ – Preliminary Results From The University of Chicago, to more than 600 transplant professionals as part of the Oral Abstract Session II on January 15, 2021 at 2:05 PM. Further details on the program and registration can be found on ASTS Winter Symposium website (https://asts.org/events-meetings/winter-symposium) ABOUT ASTS AND THE 21st ANNUAL STATE OF THE ART WINTER SYMPOSIUM The American Society of Transplant Surgeons represents approximately 1,900 professionals dedicated to excellence in transplantation surgery. ASTS advances the art and science of transplant surgery through patient care, research, education, and advocacy. ASTS 21st Annual State of the Art Winter Symposium will be held virtually January 14 – 16, 2021. Beginning on January 14, the sessions will be available virtually to disseminate the latest science in transplantation surgery. ABOUT SERNOVA'S CLINICAL TRIAL Sernova is conducting a Phase I/II non-randomized, unblinded, single-arm, company-sponsored trial to assess the safety and tolerability of islet transplantation into the company's patented Cell Pouch in diabetic subjects with hypoglycemia unawareness. The primary objective of the study is to assess the safety of the Cell Pouch following implantation and transplantation. The secondary objective is to assess efficacy through a series of defined measures. Patients enrolled in Sernova's clinical trial are incapable of producing C-peptide, a biomarker for insulin produced by islet cells. Eligible subjects are implanted with Cell Pouches. Following the development of vascularized tissue chambers within the Cell Pouch, subjects are then stabilized on immunosuppression, and a dose of purified islets, under strict release criteria, is transplanted into the Cell Pouch. A sentinel pouch is removed for an early assessment of the islet transplant. Subjects are followed for additional safety and efficacy measures for approximately six months. At this point, a decision will be made with regards to the transplant of a second islet dose with subsequent safety and efficacy follow-up. Patients will be then further followed for one year to assess longer-term safety and efficacy. For more information on the clinical trial, please visit www.clinicaltrials.gov/ct2/show/NCT03513939. For more information on enrollment and recruitment details please visit www.pwitkowski.org/sernova.

News News

https://www.beprofiteer.com/nlhtm/show.php?id=317

Ich bleibe weiter auf der Lauer und steige hoffentlich zur richtigen Zeit wieder ein 👍

😅

Aber vielleicht strebt ja auch unser Phil ein Listing an der Nasdaq an?! Wer weiß was es für Überraschungen gibt. Oder eben es passiert wie bisher: Nichts😂

Zudem zieht ein höherer Nennwert einer Aktie oft seriösere Investoren an. Ist halt bis jetzt ein Canadian Penny. Und die haben allgemein nicht den besten Ruf 😔

Also einen Reverse Split würde ich persönlich sehr begrüssen😄 weniger Aktien im Float, kein Penny mehr also dadurch uninteressant für die Penny Flippers und ab 1$ Listing an der Nasdaq möglich.

Das habe ich verpasst Tomes. Schauen wir mal was 2021 bringt und ich hoffe nicht auf sowas wie Aktiensplits usw.

Abbsie heute am späten Nachmittag war übrigens mal wieder ein kleines Stangerl dabei!

Wenn es hier mal abgeht sehen wir den Euro relativ schnell! Und dann geht der Spaß erst richtig los.........Mein Plan!